» Articles » PMID: 16585561

Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response During Cross-priming

Overview
Journal J Immunol
Date 2006 Apr 6
PMID 16585561
Citations 147
Authors
Affiliations
Soon will be listed here.
Abstract

Type I IFN (IFN-alphabeta), which is produced rapidly in response to infection, plays a key role in innate immunity and also acts as a stimulus for the adaptive immune response. We have investigated how IFN-alphabeta induces cross-priming, comparing CD8+ T cell responses generated against soluble protein Ags in the presence or absence of IFN-alphabeta. Injection of IFN-alpha was found to prolong the proliferation and expansion of Ag-specific CD8+ T cells, which was associated with marked up-regulation of IL-2 and IL-15 receptors on Ag-specific cells and expression of IL-15 in the draining lymph node. Surprisingly, neither IL-2 nor IL-15 was required for IFN-alpha-induced cross-priming. Conversely, expression of the IFN-alphabetaR by T cells was shown to be necessary for effective stimulation of the response by IFN-alpha. The finding that T cells represent direct targets of IFN-alphabeta-mediated stimulation reveals an additional mechanism by which the innate response to infection promotes adaptive immunity.

Citing Articles

Inhibiting Tyrosine Kinase 2 Ameliorates Antiphospholipid Syndrome Nephropathy.

Tang K, Chen Y, Chen T, Chao Y, Kung S, Chen D Mediators Inflamm. 2025; 2024:5568822.

PMID: 39742289 PMC: 11688129. DOI: 10.1155/mi/5568822.


Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy.

Li T, Guo S, Xu C, Zhang M, Lyu C, Xu H J Immunother Cancer. 2024; 12(11).

PMID: 39581706 PMC: 11590841. DOI: 10.1136/jitc-2024-010534.


Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironment.

Lim J, La J, Kim H, Kang I, Kang B, Ku K iScience. 2024; 27(9):110810.

PMID: 39286510 PMC: 11404196. DOI: 10.1016/j.isci.2024.110810.


The Micro-Immunotherapy Medicine 2LPAPI Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells.

Jacques C, Marchand F, Chatelais M, Albinet V, Coustal C, Floris I Cancers (Basel). 2024; 16(7).

PMID: 38611099 PMC: 11010933. DOI: 10.3390/cancers16071421.


A clinically attenuated double-mutant of porcine reproductive and respiratory syndrome virus-2 that does not prompt overexpression of proinflammatory cytokines during co-infection with a secondary pathogen.

Su C, Kim J, Tang J, Hung Y, Zuckermann F, Husmann R PLoS Pathog. 2024; 20(3):e1012128.

PMID: 38547254 PMC: 11003694. DOI: 10.1371/journal.ppat.1012128.